Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 3Turcot syndrome 2Medulloblastoma 2Triple Negative Breast Neoplasms 1Solid Tumor 1Rhabdoid Tumor 1Recurrence 1Rectal Neoplasms 1Pyloric Stenosis, Hypertrophic 1Pinealoma 1Peutz-Jeghers Syndrome 1Pancreatic Neoplasms 1Oropharyngeal Neoplasms 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Mouth Neoplasms 1Locally Advanced Rectal Cancer 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Ependymoma 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1Carcinoma 1Adenomatous Polyposis Coli 1

Interventions

pembrolizumab 57Carboplatin 34Paclitaxel 24Cyclophosphamide 23Capecitabine 18sacituzumab govitecan 16Specimen Handling 15130-nm albumin-bound paclitaxel 15toripalimab 11Drug Therapy 11Biopsy 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Taxes 9Epirubicin 9durvalumab 8Albumin-Bound Paclitaxel 8olaparib 7camrelizumab 7Gemcitabine 7Doxorubicin 7Docetaxel 7fludarabine 6famitinib 5Nivolumab 5Injections 5atezolizumab 4abemaciclib 4Trastuzumab 4Standard of Care 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Triple Negative Breast Neoplasms × Celecoxib × Clear all
NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Université de Sherbrooke

Phase 2 Recruiting
30 enrolled
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡